Skip to main content

Advertisement

Log in

Ganoderic Acid A Attenuates IL-1β-Induced Inflammation in Human Nucleus Pulposus Cells Through Inhibiting the NF-κB Pathway

  • Original Article
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Intervertebral disc (IVD) degeneration is a major cause of low back pain associated with several pathological changes in the IVD, including dysfunction of nucleus pulposus (NP) cells. Ganoderic Acid A (GAA), one of triterpenoid extracts of Ganoderma lucidum (G. lucidum), has been reported to possess anti-inflammatory effect. In the current study, we aimed to evaluate the effect of Ganoderic Acid A (GAA) on the interleukin-1β (IL-1β)-induced inflammation in human NP cells. Our results showed that the IL-1β-stimulated production of inflammatory mediators including nitric oxide (NO), prostaglandin E2 (PGE2), inducible nitric oxide synthase (iNOS) and cyclooxygenase (COX)-2 were suppressed by GAA. In addition, treatment of NP cells with GAA significantly inhibited the production of inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) in IL-1β-stimulated human NP cells. GAA improved the reduced expression levels of extracellular matrix (ECM) proteins, collagen II and aggrecan in IL-1β-stimulated human NP cells. GAA also alleviated IL-1β-induced the levels of matrix metalloproteinase (MMP)-3 and MMP-13. Furthermore, GAA inhibited the IL-1β-induced upregulation of the phosphorylation of p65 and downregulation of IκBα. Taken together, these findings indicated that GAA alleviated IL-1β-induced inflammation and ECM degradation in NP cells through regulating NF-κB pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Availability of Data and Material

The datasets analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Vergroesen, P.P., I. Kingma, K.S. Emanuel, R.J. Hoogendoorn, T.J. Welting, B.J. van Royen, J.H. van Dieen, and T.H. Smit. 2015. Mechanics and biology in intervertebral disc degeneration: A vicious circle. Osteoarthritis Cartilage 23: 1057–1070.

    Article  Google Scholar 

  2. Kos, N., L. Gradisnik, and T. Velnar. 2019. A brief review of the degenerative intervertebral disc disease. Med Arch 73: 421–424.

    Article  Google Scholar 

  3. Priyadarshani, P., Y. Li, and L. Yao. 2016. Advances in biological therapy for nucleus pulposus regeneration. Osteoarthritis Cartilage 24: 206–212.

    Article  CAS  Google Scholar 

  4. Risbud, M.V., and I.M. Shapiro. 2014. Role of cytokines in intervertebral disc degeneration: Pain and disc content. Nature Reviews Rheumatology 10: 44–56.

    Article  CAS  Google Scholar 

  5. Cazzanelli, P., and K. Wuertz-Kozak. 2020. MicroRNAs in intervertebral disc degeneration, apoptosis, inflammation, and mechanobiology. International Journal of Molecular Sciences 21: 3601.

    Article  CAS  Google Scholar 

  6. Choi, H., Z.I. Johnson, and M.V. Risbud. 2015. Understanding nucleus pulposus cell phenotype: A prerequisite for stem cell based therapies to treat intervertebral disc degeneration. Current Stem Cell Research & Therapy 10: 307–316.

    Article  CAS  Google Scholar 

  7. Zhang, F., X. Zhao, H. Shen, and C. Zhang. 2016. Molecular mechanisms of cell death in intervertebral disc degeneration (Review). International Journal of Molecular Medicine 37: 1439–1448.

    Article  CAS  Google Scholar 

  8. Wan, B., Li, Y., Sun, S., Yang, Y., Lv, Y., Wang, L., Song, M., Chen, M., Wu, C., Pan, H. and Zhang, X. 2019. Ganoderic acid A attenuates lipopolysaccharide-induced lung injury in mice. Bioscience Report 39: BSR20190301.

  9. Bao, H., Li, H., Jia, Y., Xiao, Y., Luo, S., Zhang, D., Han, L., Dai, L., Xiao, C., Feng, L. and Feng, Y. 2021. Ganoderic acid A exerted antidepressant-like action through FXR modulated NLRP3 inflammasome and synaptic activity. Biochemical Pharmacology 114561.

  10. Cheng, Y., and Xie, P. 2019. Ganoderic acid A holds promising cytotoxicity on human glioblastoma mediated by incurring apoptosis and autophagy and inactivating PI3K/AKT signaling pathway. Journal of Biochemical and Molecular Toxicology 33: e22392.

  11. Yang, Y., H. Zhou, W. Liu, J. Wu, X. Yue, J. Wang, L. Quan, H. Liu, L. Guo, Z. Wang, X. Lian, and Q. Zhang. 2018. Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway. Oncology Letters 16: 6515–6521.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Kang, L.H., G.W. Zhang, J.F. Zhang, B. Qin, and H.J. Guan. 2020. Ganoderic acid A protects lens epithelial cells from UVB irradiation and delays lens opacity. Chinese Journal of Natural Medicines 18: 934–940.

    Article  Google Scholar 

  13. Zhang, W., W. Yu, X. Ding, C. Yin, J. Yan, E. Yang, F. Guo, D. Sun, and W. Wang. 2019. Self-assembled thermal gold nanorod-loaded thermosensitive liposome-encapsulated ganoderic acid for antibacterial and cancer photochemotherapy. Artif Cells Nanomed Biotechnol 47: 406–419.

    Article  CAS  Google Scholar 

  14. Cao, T., C. Tang, L. Xue, M. Cui, and D. Wang. 2020. Protective effect of ganoderic acid A on adjuvant-induced arthritis. Immunology Letters 226: 1–6.

    Article  CAS  Google Scholar 

  15. Risbud, M.V., A. Guttapalli, D.G. Stokes, D. Hawkins, K.G. Danielson, T.P. Schaer, T.J. Albert, and I.M. Shapiro. 2006. Nucleus pulposus cells express HIF-1 alpha under normoxic culture conditions: A metabolic adaptation to the intervertebral disc microenvironment. Journal of Cellular Biochemistry 98: 152–159.

    Article  CAS  Google Scholar 

  16. Choi, H., C. Merceron, L. Mangiavini, E.L. Seifert, E. Schipani, I.M. Shapiro, and M.V. Risbud. 2016. Hypoxia promotes noncanonical autophagy in nucleus pulposus cells independent of MTOR and HIF1A signaling. Autophagy 12: 1631–1646.

    Article  CAS  Google Scholar 

  17. Su, X., B. Liu, F. Gong, J. Yin, Q. Sun, Y. Gao, Z. Lv, and X. Wang. 2019. Isofraxidin attenuates IL-1beta-induced inflammatory response in human nucleus pulposus cells. Journal of Cellular Biochemistry 120: 13302–13309.

    Article  CAS  Google Scholar 

  18. Bai, X., Ding, W., Yang, S., and Guo, X. 2019. Higenamine inhibits IL-1-beta-induced inflammation in human nucleus pulposus cells. Bioscience Report 39: BSR20190857.

  19. Zhang, Y., F. He, Z. Chen, Q. Su, M. Yan, Q. Zhang, J. Tan, L. Qian, and Y. Han. 2019. Melatonin modulates IL-1beta-induced extracellular matrix remodeling in human nucleus pulposus cells and attenuates rat intervertebral disc degeneration and inflammation. Aging (Albany NY) 11: 10499–10512.

    Article  CAS  Google Scholar 

  20. Liu, F., K. Shi, J. Dong, Z. Jin, Y. Wu, Y. Cai, T. Lin, Q. Cai, L. Liu, and Y. Zhang. 2020. Ganoderic acid A attenuates high-fat-diet-induced liver injury in rats by regulating the lipid oxidation and liver inflammation. Archives of Pharmacal Research 43: 744–754.

    Article  CAS  Google Scholar 

  21. Wen, G., T. Li, H. He, X. Zhou, and J. Zhu. 2020. Ganoderic acid A inhibits bleomycin-induced lung fibrosis in mice. Pharmacology 105: 568–575.

    Article  CAS  Google Scholar 

  22. Lixin, X., Lijun, Y. and Songping, H. 2019. Ganoderic acid A against cyclophosphamide-induced hepatic toxicity in mice. Journal of Biochemical and Molecular Toxicology 33: e22271.

  23. Chi, B., S. Wang, S. Bi, W. Qin, D. Wu, Z. Luo, S. Gui, D. Wang, X. Yin, and F. Wang. 2018. Effects of ganoderic acid A on lipopolysaccharide-induced proinflammatory cytokine release from primary mouse microglia cultures. Experimental and Therapeutic Medicine 15: 847–853.

    CAS  PubMed  Google Scholar 

  24. Nedresky, D., Reddy, V., Singh, G. 2021. Anatomy, back, nucleus pulposus, StatPearls. Treasure Island (FL).

  25. Navone, S.E., G. Marfia, A. Giannoni, M. Beretta, L. Guarnaccia, R. Gualtierotti, D. Nicoli, P. Rampini, and R. Campanella. 2017. Inflammatory mediators and signalling pathways controlling intervertebral disc degeneration. Histology and Histopathology 32: 523–542.

    CAS  PubMed  Google Scholar 

  26. Wuertz, K., and L. Haglund. 2013. Inflammatory mediators in intervertebral disk degeneration and discogenic pain. Global Spine J 3: 175–184.

    Article  Google Scholar 

  27. Khan, A.N., H.E. Jacobsen, J. Khan, C.G. Filippi, M. Levine, R.A. Lehman Jr., K.D. Riew, L.G. Lenke, and N.O. Chahine. 2017. Inflammatory biomarkers of low back pain and disc degeneration: A review. Annals of the New York Academy of Sciences 1410: 68–84.

    Article  Google Scholar 

  28. Zhang, C.C., J.S. Zhou, J.G. Hu, X. Wang, X.S. Zhou, B.A. Sun, C. Shao, and Q. Lin. 2013. Effects of IGF-1 on IL-1beta-induced apoptosis in rabbit nucleus pulposus cells in vitro. Molecular Medicine Reports 7: 441–444.

    Article  CAS  Google Scholar 

  29. Lu, L., J. Hu, Q. Wu, Y. An, W. Cui, J. Wang, and Z. Ye. 2019. Berberine prevents human nucleus pulposus cells from IL1betainduced extracellular matrix degradation and apoptosis by inhibiting the NFkappaB pathway. International Journal of Molecular Medicine 43: 1679–1686.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Zhao, C.Q., L.M. Wang, L.S. Jiang, and L.Y. Dai. 2007. The cell biology of intervertebral disc aging and degeneration. Ageing Research Reviews 6: 247–261.

    Article  Google Scholar 

  31. Sampara, P., R.R. Banala, S.K. Vemuri, G.R. Av, and S. Gpv. 2018. Understanding the molecular biology of intervertebral disc degeneration and potential gene therapy strategies for regeneration: A review. Gene Therapy 25: 67–82.

    Article  CAS  Google Scholar 

  32. Sztrolovics, R., M. Alini, P.J. Roughley, and J.S. Mort. 1997. Aggrecan degradation in human intervertebral disc and articular cartilage. The Biochemical Journal 326 (Pt 1): 235–241.

    Article  CAS  Google Scholar 

  33. Eyre, D.R., and H. Muir. 1977. Quantitative analysis of types I and II collagens in human intervertebral discs at various ages. Biochimica et Biophysica Acta 492: 29–42.

    Article  CAS  Google Scholar 

  34. Quero, L., M. Klawitter, A. Schmaus, M. Rothley, J. Sleeman, A.N. Tiaden, J. Klasen, N. Boos, M.O. Hottiger, K. Wuertz, and P.J. Richards. 2013. Hyaluronic acid fragments enhance the inflammatory and catabolic response in human intervertebral disc cells through modulation of toll-like receptor 2 signalling pathways. Arthritis Research & Therapy 15: R94.

    Article  Google Scholar 

  35. Viatour, P., M.P. Merville, V. Bours, and A. Chariot. 2005. Phosphorylation of NF-kappaB and IkappaB proteins: Implications in cancer and inflammation. Trends in Biochemical Sciences 30: 43–52.

    Article  CAS  Google Scholar 

Download references

Funding

This study was supported by our hospital.

Author information

Authors and Affiliations

Authors

Contributions

Sihua Zheng wrote this paper. Sihua Zheng, Jianmin Ma, and Xuezheng Zhao performed the experiments. Xuezi Yu analyzed the data. Yong Ma designed this study. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yong Ma.

Ethics declarations

Ethics Approval and Consent to Participate

This study was approved and supervised by the ethics committee of Xixi Hospital of Hangzhou (Hangzhou, China). All the subjects have signed the informed consents. Each step was rigorously performed according to the code of ethics.

Consent for Publication

Not applicable.

Competing Interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zheng, S., Ma, J., Zhao, X. et al. Ganoderic Acid A Attenuates IL-1β-Induced Inflammation in Human Nucleus Pulposus Cells Through Inhibiting the NF-κB Pathway. Inflammation 45, 851–862 (2022). https://doi.org/10.1007/s10753-021-01590-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10753-021-01590-0

KEY WORDS

Navigation